LPL Financial’s Oragenics OGEN Stock Holding History

LPL Financial’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11	Closed	-$19K	–	4285
2021 Q1	$19K	Buy	+11	New	+$20K	﹤0.01%	4051

Other funds holding OGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBF

Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

LPL Financial's OGEN Position: Q2 2021 in Review

LPL Financial sold out of Oragenics (OGEN) in Q2 2021, closing a stake of 11 shares — an estimated $19K sold.

LPL Financial first reported a position in OGEN in Q1 2021 and held it in 1 quarter. The position peaked at $19K in Q1 2021. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2021.

LPL Financial reported no remaining Oragenics position as of Q2 2021 after selling out during the quarter.
LPL Financial sold 11 Oragenics shares in Q2 2021, an estimated $19K.
LPL Financial first reported a position in Oragenics in Q1 2021 and held it in 1 quarter.
LPL Financial's Oragenics position peaked at $19K in Q1 2021.
17 funds tracked by Wall St. Rank held Oragenics as of Q2 2021.

Based on LPL Financial's 13F filing for Q2 2021, filed 13 Aug 2021.